What is Zacks Research's Estimate for PBH FY2026 Earnings?

Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) - Equities research analysts at Zacks Research boosted their FY2026 earnings estimates for Prestige Consumer Healthcare in a note issued to investors on Monday, July 14th. Zacks Research analyst R. Department now anticipates that the company will post earnings of $4.74 per share for the year, up from their prior forecast of $4.73. The consensus estimate for Prestige Consumer Healthcare's current full-year earnings is $4.50 per share.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its earnings results on Thursday, May 8th. The company reported $1.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.30 by $0.02. The business had revenue of $296.52 million during the quarter, compared to analysts' expectations of $289.36 million. Prestige Consumer Healthcare had a net margin of 18.86% and a return on equity of 12.87%. The company's revenue for the quarter was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.02 EPS.

Several other research analysts also recently issued reports on the stock. Royal Bank Of Canada raised shares of Prestige Consumer Healthcare to a "hold" rating in a research report on Thursday, May 8th. Wall Street Zen raised shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $93.33.

Prestige Consumer Healthcare Stock Performance

Prestige Consumer Healthcare stock traded up $0.03 during midday trading on Thursday, hitting $75.20. 565,155 shares of the company's stock were exchanged, compared to its average volume of 315,394. Prestige Consumer Healthcare has a 12-month low of $64.94 and a 12-month high of $90.04. The company has a debt-to-equity ratio of 0.55, a quick ratio of 2.82 and a current ratio of 4.20. The stock has a market cap of $3.72 billion, a price-to-earnings ratio of 17.53, a price-to-earnings-growth ratio of 2.25 and a beta of 0.43. The firm's 50 day simple moving average is $83.39 and its 200 day simple moving average is $82.29.

Hedge Funds Weigh In On Prestige Consumer Healthcare

A number of institutional investors have recently modified their holdings of the company. Kayne Anderson Rudnick Investment Management LLC increased its position in Prestige Consumer Healthcare by 45.3% during the first quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,580,819 shares of the company's stock worth $135,903,000 after purchasing an additional 493,199 shares during the last quarter. Geode Capital Management LLC increased its position in Prestige Consumer Healthcare by 1.7% during the fourth quarter. Geode Capital Management LLC now owns 1,348,745 shares of the company's stock worth $105,342,000 after purchasing an additional 21,951 shares during the last quarter. Invesco Ltd. increased its position in Prestige Consumer Healthcare by 24.7% during the first quarter. Invesco Ltd. now owns 1,321,800 shares of the company's stock worth $113,635,000 after purchasing an additional 261,537 shares during the last quarter. Congress Asset Management Co. grew its stake in Prestige Consumer Healthcare by 1.8% during the second quarter. Congress Asset Management Co. now owns 1,009,595 shares of the company's stock worth $80,616,000 after buying an additional 18,015 shares during the period. Finally, Westwood Holdings Group Inc. grew its stake in Prestige Consumer Healthcare by 7.1% during the first quarter. Westwood Holdings Group Inc. now owns 861,282 shares of the company's stock worth $74,044,000 after buying an additional 56,802 shares during the period. Institutional investors and hedge funds own 99.95% of the company's stock.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.